Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2017 1
2018 2
2019 1
2020 6
2021 10
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for kervella d
Search for Kervela D instead (1 results)
How to measure human leukocyte antigen-specific B cells.
Kervella D, Torija A, Zúñiga JM, Bestard O. Kervella D, et al. Curr Opin Organ Transplant. 2023 Oct 1;28(5):345-354. doi: 10.1097/MOT.0000000000001097. Epub 2023 Aug 18. Curr Opin Organ Transplant. 2023. PMID: 37678170 Review.
New immunosuppressive agents in transplantation.
Kervella D, Blancho G. Kervella D, et al. Presse Med. 2022 Dec;51(4):104142. doi: 10.1016/j.lpm.2022.104142. Epub 2022 Oct 15. Presse Med. 2022. PMID: 36252821
Questions about the BEST-Fluids trial.
Masset C, Chapelet A, Dumont R, Ville S, Garandeau C, Houzet A, Kervella D, Dantal J, Blancho G, Cantarovich D, Giral M, Figueres L; Nantes DIVAT Consortium. Masset C, et al. Among authors: kervella d. Lancet. 2024 Mar 9;403(10430):909-910. doi: 10.1016/S0140-6736(23)02682-X. Lancet. 2024. PMID: 38460985 No abstract available.
Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression.
Danger R, Le Berre L, Cadoux M, Kerleau C, Papuchon E, Mai HL, Nguyen TV, Guérif P, Morelon E, Thaunat O, Legendre C, Anglicheau D, Lefaucheur C, Couzi L, Del Bello A, Kamar N, Le Quintrec M, Goutaudier V, Renaudin K, Giral M, Brouard S; DIVAT Consortium. Danger R, et al. Kidney Int. 2023 Jun;103(6):1167-1179. doi: 10.1016/j.kint.2023.03.019. Epub 2023 Mar 27. Kidney Int. 2023. PMID: 36990211
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Moreau A, Kervella D, Bouchet-Delbos L, Braudeau C, Saïagh S, Guérif P, Limou S, Moreau A, Bercegeay S, Streitz M, Sawitzki B, James B, Harden PN, Game D, Tang Q, Markmann JF, Roberts ISD, Geissler EK, Dréno B, Josien R, Cuturi MC, Blancho G; DIVAT consortium. Moreau A, et al. Among authors: kervella d. Kidney Int. 2023 Mar;103(3):627-637. doi: 10.1016/j.kint.2022.08.037. Epub 2022 Oct 26. Kidney Int. 2023. PMID: 36306921
Time-Limited Therapy with Belatacept in Kidney Transplant Recipients.
Letellier T, Kervella D, Sadek A, Masset C, Garandeau C, Fourgeux C, Gourain V, Poschmann J, Blancho G, Ville S, On Behalf Of The Divat Consortium. Letellier T, et al. Among authors: kervella d. J Clin Med. 2022 Jun 6;11(11):3229. doi: 10.3390/jcm11113229. J Clin Med. 2022. PMID: 35683619 Free PMC article.
37 results